Fig. 4
From: Adaptive design for identifying maximum tolerated dose early to accelerate dose-finding trial
Percent change non-EI version to EI version in average study duration. FS1: Fixed Scenario 1; FS2: Fixed Scenario 2; FS3: Fixed Scenario 3; FS4: Fixed Scenario 4; FS5: Fixed Scenario 5; FS6: Fixed Scenario 6; RS1: Random Scenario 1; and RS2: Random Scenario 2. EI: Early identification of MTD